|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 17/00 | (2006.01) |
| A61K 38/47 | (2006.01) | ||
| A61K 38/48 | (2006.01) | ||
| A61K 38/46 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Patento numeris | 2947100 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15152332.1 |
| Europos patento paraiškos padavimo data | 2010-01-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 142718 P | 2009-01-06 | US | |
| 153279 P | 2009-02-17 | US | |
| 170856 P | 2009-04-20 | US |
| (72) |
Fallon, Joan M., US
Heil, Matthew, US
Fallon, James J., US
|
| (73) |
Galenagen, LLC,
411 Theodore Fremd Avenue, Suite 206, Rye, NY 10580,
US
|
| (54) | Oral compositions for the treatment or the prevention of infections by E. Coli |
| Oral compositions for the treatment or the prevention of infections by E. Coli |